108917 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7); Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases Thymidine kinase (2.7.1.21)
STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS
#2COMPOSITIONS AND METHODS FOR IDENTIFICATION OF VHH ANTIBODIES THAT BIND A TARGET ANTIGEN
#3ZIKV-BASED GENE DELIVERY SYSTEM
#4ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER
#5ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER
#6ADENO-ASSOCIATED VIRAL (AAV) VECTORS FOR TISSUE-TARGETED EXPRESSION OF THERAPEUTIC GENES
#7RNA Trans-Splicing Molecule
#8FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD
#9ONCOLYTIC VIRUS AND USES THEREOF
#10CELLS WITH SUSTAINED TRANSGENE EXPRESSION
#11BIG-IN: A VERSATILE PLATFORM FOR LOCUS-SCALE GENOME REWRITING AND VERIFICATION
#12VECTORS AND METHODS FOR IN VIVO TRANSDUCTION
#13Gene therapy vector with minimizing recombination, recombinant retrovirus comprising the vector, and pharmaceutical composition for preventing or treating cancer comprising the recombinant retrovirus
#14ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#15RECOMBINANT VACCINIA VIRUS
#16ORTHOGONAL SAFETY SWITCHES TO ELIMINATE GENETICALLY ENGINEERED CELLS
#17AAV-BASED DELIVERY OF THYMINE KINASE 2
#18THYMIDINE KINASE GENE
#19Cyclin G1 inhibitors and related methods of treating cancer
#20METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS
#21ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#22DNA, EXPRESSION VECTOR, TRANSCRIPT, CELL, PHARMACEUTICAL COMPOSITION, AND MEDICINE
#23CHIMERIC CYTOKINE RECEPTORS
#24SUPERACTIVE MUTANT THYMIDINE KINASE FOR USE IN CANCER THERAPY
#25Recombinant vaccinia virus and methods of use thereof
#26Thymidine kinase gene
#27Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy
#28Transgene-Cytotoxic Combination Therapy
#29Engineering stem cells for cancer therapy
#30Cyclin G1 inhibitors and related methods of treating cancer
#31Thymidine kinase diagnostic assay for gene therapy applications
#32Methods and compositions for the positive selection of protein destabilizers
#33Methods for treating cells containing fusion genes
#34Elimination of proliferating cells from stem cell-derived grafts
#35Site-specific integration of transgenes
#36Thymidine kinase
#37MONOCLONAL ANTI-TK1 ANTIBODIES
#38Thymidine kinase diagnostic assay for gene therapy applications
#39Thymidine kinase gene
#40Gene therapy vector system and prodrug genes
#41AGENTS, SYSTEMS AND METHODS FOR TREATING CANCER
#42ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#43Combination Therapy For Cancer
#44CONDITIONAL RESCUE SYSTEM, CELLS, AND METHODS
#45Methods for treating cells containing fusion genes
#46Methods and Vectors to Produce Vector Free Induced Pluripotent Stem Cells
#47CONDITIONAL CYTOTOXIC GENE THERAPY VECTOR FOR SELECTABLE STEM CELL MODIFICATION FOR ANTI HIV GENE THERAPY
#48LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#49Monoclonal anti-TK1 antibodies
#50FGF-10 COMPLEXES
#51RNA trans-splicing molecule (RTM) for use in the treatment of cancer
#52METHOD FOR THE REPAIR OF MUTATED RNA FROM GENETICALLY DEFECTIVE DNA AND FOR THE SPECIFIC DESTRUCTION OF TUMOR CELLS BY RNA TRANS-SPLICING, AND A METHOD FOR THE DETECTION OF NATURALLY TRANS-SPLICED CELLULAR RNA
#53Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors
#54Method for identifying and treating a patient having tumor lesions comprising administering a gene therapy retroviral vector particle comprising a mutated HSV-thymidine kinase (HSV-TK) polynucleotide
#55Thymidine kinase gene
#56Prodrug activation in cancer cells using molecular switches
#57FGF-10 Complexes
#58NON-IMMUNOGENIC POSITRON EMISSION TOMOGRAPHY REPORTER GENE SYSTEMS
#59Thymidine kinase
#60Compounds and methods
#61Thymidine kinase
#62Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
#63Polynucleotides Encoding Thymidine Kinase Mutants
#64F1B-TMIR plasmid vector and transgenic mouse
#65Thymidine Kinase Mutants
#66Compositions and methods for causing neurite outgrowth
#67Treating Insulin Secreting Cells
#68LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#69MN Gene and Protein
#70Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#71METHODS AND COMPOSITIONS FOR CANCER THERAPY USING A NOVEL ADENOVIRUS
#72Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
#73Nucleic acid molecules encoding thymidine kinase fusion proteins
#74Prodrug activation in cancer cells using molecular switches
#75Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
#76F1B-TMIR plasmid vector and transgenic mouse
#77MN Gene and Protein
#78VECTOR ENCODING THERAPEUTIC POLYPEPTIDE AND SAFETY ELEMENTS TO CLEAR TRANSDUCED CELLS
#79Exposed proliferation-related peptides, ligands and methods employing the same
#80Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
#81Nucleic acids encoding fusion proteins having thymidine kinase and guanylate kinase activities
#82Cell death pre-mRNA-encoding DNA
#83Fusion proteins having thymidine kinase and guanylate kinase activities
#84Methods and compositions for cancer therapy using a novel adenovirus
#85Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereof
#86Tumor therapy with replication competent sindbis viral vectors
#87Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#88Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
#89Thymidine kinase
#90Raccoon Poxvirus Expressing Genes of Porcine Virus
#91MN Gene and Protein
#92MN gene and protein
#93MN Gene and Protein
#94REVERSIBLY IMMORTALIZED HEPATOCYTES AND METHODS OF USE
#95Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#96Canine herpesvirus thymidine kinase nucleic acid molecules
#97Plant deoxyribonucleoside kinase enzymes and their use
#98Nucleotide sequence for treating cancer and infection
#99Compositions, kits and assays containing reagents directed to cortactin and an ARG/ABL protein kinase
#100Method for the repair of mutated RNA from genetically defective DNA and for the specific destruction of tumor cells by RNA trans-splicing, and a method for the detection of naturally trans-spliced cellular RNA
#101Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods
#102Pharmaceutical composition comprising a thymidine kinase polynucleotide
#103Packaging cells
#104Treating hyperinsulinemia by killing beta cells with cytotoxic gene
#105Promoter driven tissue specific cytotoxic agents and title methods of use